RxDoctor Payments Data

Stephen Kemple, DO

Anesthesiology · Missoula, MTNPI 1336138478

Payments from drug & device makers

What this record shows

Medtronic accounts for 75.9% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2022 at $2,764 and has fallen 93.1% since, to $190 in 2025. Among anesthesiology clinicians in MT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,965in general payments, 2019–2025

Across 92 payments — averaging $64.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$5K
  • Boston Scientific$531
  • AbbVie$220
  • Collegium Pharmaceutical, Inc.$97
  • Supernus Pharmaceuticals, Inc.$94
  • Piramal Critical Care$92
  • plus $407 from 12 others

What the payments were for

  • Travel & lodging$2,84448%
  • Food & beverage$3,12152%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,965 in reported general payments places this provider in the 95th percentile of 185 anesthesiology providers in Montana.

See all anesthesiology providers in Montana

Medicare billing

Part B allowed, 2024
$73,164
Medicare patients
213
Services billed
710

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fentanyl18$6,155
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen65$2,003
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl11$1,684
Lidocaine14$1,371
Oxycodone Hcl70$901
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen48$835
Morphine Sulfate ErMorphine Sulfate34$779
Hydromorphone Hcl35$676
Gabapentin78$535
Pregabalin42$415
Levetiracetam11$373
Methocarbamol22$220
Methadone Hcl12$206
Topiramate17$118
Baclofen17$89

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Upsher-smith Laboratories LLCTopiramate$18$11817 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 185 anesthesiology providers in Montana.

Other anesthesiology in Missoula

See the full list for Montana

Where these figures come from

Is this you, or does something look wrong? →